Science-Driven Pet Health Company Has Invested Millions in Research and Development
SOUTH PORTLAND, Maine – November 9, 2026 – ElleVet Sciences, a pet health company committed to advancing the science of animal health, has announced the launch of a new product line that combines clinically studied CBD + CBDA with Natural Compounds™ such as Ashwagandha to support dogs, cats and other animals experiencing joint discomfort, stress and cognitive challenges.
Founded in 2017, ElleVet set out to improve the quality of life for pets by creating a supplement company that approached product development with the rigor often reserved for pharmaceutical research and put science at the center of everything it does.
Research shows that more than 60% of dogs have confirmed joint issues, but only about 20–25% are brought to a veterinarian for joint discomfort as they get older. That gap highlights the importance of supporting joint health early, before discomfort becomes a bigger concern.
The company has worked alongside biochemists, veterinary clinical researchers, cannabinoid and botanist experts and has invested millions of dollars in research and development.
This research has helped ElleVet expand its focus beyond cannabinoids to explore how other naturally derived compounds can support pet health throughout their lives. That work has led to the development of its new Natural Compounds™ products, which combine proprietary CBD + CBDA with compounds such as Ashwagandha.
“We are quite excited about our new mobility product since prior users of ElleVet CBD/CBDA showed that more than 80% of the dogs provided the new ElleVet Veterinary Strength Joint and Mobility product for 4 weeks showed significant mobility improvement using a validated survey,” said Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR and Chief Veterinary Medical Officer at ElleVet Sciences. “Our new stress product showed more than 70% of the dogs using our original product for stress reported significant improvement stress related behavior. This new formulation is showing that we could do even better with the addition of new Natural Compounds.”
Over the past eight years, ElleVet has conducted more than 40 clinical studies and R&D projects and published more than 23 peer-reviewed papers examining the effects of CBD and CBDA on pet health.
“This is the biggest product launch since ElleVet was founded and I am incredibly proud of the innovation we have brought to the pet health industry, innovation that has significantly improved the lives of hundreds of thousands of pets,” said Christian Kjaer, cofounder and CEO of ElleVet Sciences. “ElleVet’s products are now as good or better than many traditional products and are increasingly becoming the first line of defense for joint health and stress by leading veterinarians.”
The new Natural Compounds™ formula will be available through participating veterinarians and online.
To learn more about ElleVet’s research you can review the white papers linked below:
- Can ElleVet Soft Chews Help Dogs Experiencing Joint Discomfort Feel More Comfortable?
- Can ElleVet Veterinary Strength Cognitive + Calm Soft Chews Help Dogs Experiencing Stress Feel Calmer?
- Can ElleVet Veterinary Strength Cognitive + Calm Soft Chews Help Dogs Experiencing Cognitive Challenges?
About ElleVet Sciences: ElleVet Sciences is a leading science-driven animal health company headquartered in South Portland, Maine. As the first organization to conduct successful clinical trials on the safety and efficacy of CBD + CBDA for pets, ElleVet continues to lead the field through research and innovation in collaboration with top veterinary professionals and institutions. The company has pioneered and patented safe, effective products for dogs, cats, and horses, offering support for mobility, stress, canine skin health, and canine brain function. Carried by thousands of veterinary clinics across the US, ElleVet is committed to improving the lives of companion animals, with both heart and science at the core of its mission.
Media Contact: [email protected]
###